Mesenchymal stem cell-derived extracellular vesicles attenuate kidney inflammation

Area of Science:

• Regenerative Medicine
• Nephrology
• Biotechnology

Background:

• Mesenchymal stem/stromal cells (MSCs) show renal repair potential but raise safety concerns.
• MSC-derived extracellular vesicles (EVs) offer a noncellular alternative for regenerative therapy.
• Metabolic syndrome and renal artery stenosis (RAS) present significant challenges in kidney disease.

Purpose of the Study:

• To investigate the renoprotective effects of MSC-derived EVs in a porcine model of metabolic syndrome with RAS.
• To determine if the anti-inflammatory capacity of EVs is mediated by encapsulated interleukin 10 (IL-10).

Main Methods:

• A porcine model with metabolic syndrome and RAS was established.
• Autologous adipose-derived MSC-EVs were administered intrarenally.
• EVs with silenced IL-10 were used to assess the role of this cytokine.
• In vivo and ex vivo analyses assessed renal blood flow, glomerular filtration rate, oxygenation, inflammation, and fibrosis.

Main Results:

• EVs were retained in the stenotic kidney and internalized by tubular cells and macrophages.
• EV treatment attenuated renal inflammation, improved medullary oxygenation, and reduced fibrosis.
• Renal blood flow and glomerular filtration rate were restored post-EV treatment.
• The renoprotective effects were diminished when using IL-10-depleted EVs.

Conclusions:

• MSC-derived EVs demonstrate significant renoprotective potential in metabolic syndrome with RAS.
• The anti-inflammatory cytokine IL-10 within EVs plays a crucial role in mediating these therapeutic effects.
• EV-based regenerative strategies represent a promising therapeutic avenue for kidney disease patients.